A Bioequivalence Study Comparing Abemaciclib Capsule and Tablet Formulations and Effect of Food on Abemaciclib Tablet Pharmacokinetics in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2017
At a glance
- Drugs Abemaciclib (Primary) ; Abemaciclib
- Indications Breast cancer; Mantle-cell lymphoma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 09 Dec 2017 Results presented at the 40th Annual San Antonio Breast Cancer Symposium.
- 03 Nov 2016 Status changed from active, no longer recruiting to completed.
- 23 Sep 2016 Planned End Date changed from 1 Nov 2016 to 1 Oct 2016.